Home Notal Vision Ltd.

Notal Vision Ltd.

Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System

12/3/18: FDA's Breakthrough Devices Program was established in late 2016 to help patients gain timely access to breakthrough technologies that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases, for which no approved or cleared treatment exists or that offer significant advantages over existing or cleared alternatives.